Cephalexin and Pifeltro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Pifeltro (doravirine). Common drug interactions include anhedonia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Pifeltro. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Pifeltro?

Pifeltro has active ingredients of doravirine. eHealthMe is studying from 476 Pifeltro users. Check the latest studies of Pifeltro.

On Aug, 09, 2026

21 people who take Cephalexin and Pifeltro together, and have interactions are studied.

Cephalexin and Pifeltro drug interactions.

What are the common drug interactions of Cephalexin and Pifeltro, by gender? *:

female:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Fatigue (feeling of tiredness)
Pain
Quality of life decreased
Renal failure (kidney dysfunction)

male:

Chronic kidney disease
Pain
Renal failure (kidney dysfunction)
Depression
Multiple injuries
Proteinuria (presence of protein in the urine)
Bone density decreased
Injury
Quality of life decreased
Anaemia (lack of blood)

What are the common drug interactions of Cephalexin and Pifeltro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Quality of life decreased
Asthenia (weakness)
Decreased activity
Fear
Insomnia (sleeplessness)

40-49:

Pain
Hallucination, auditory (perceiving sounds without auditory stimulus)
Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
Myalgia (muscle pain)
Osteopenia (a condition where bone mineral density is lower than normal)
Weight increased
Proteinuria (presence of protein in the urine)
Bone density decreased
Depression
Injury

50-59:

Anxiety
Chronic kidney disease
Pain
Renal failure (kidney dysfunction)
Emotional distress
Renal tubular necrosis (death of kidney tubules)

60+:

n/a

What are the existing conditions these people have? *

Hiv Infection: 21 people, 100.00%
Stress And Anxiety: 3 people, 14.29%
Seborrheic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 3 people, 14.29%
Rosacea (a skin condition that causes facial redness): 3 people, 14.29%
Rickets (softening of bones): 3 people, 14.29%
Muscle Spasms (muscle contraction): 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Erection Problems: 3 people, 14.29%
Depression: 3 people, 14.29%
Acne (skin problems that cause pimples): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Pifeltro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously